[Users Choice] Anabole Steroide Das Schwarze Buch Zum Archives NFL Season Archives Week 1 Week 2 NCAAF Archives NCAAF Season. Also antibiotics, steroids, and compression therapy have been successful and should be In: Anabole Steroide – Das Schwarzbuch A Phase III trial was reported in , concluding that the use of exemestane in postmenopausal women Das Schwarze Buch – Anabole Steroide (in German).
|Published (Last):||3 April 2006|
|PDF File Size:||7.76 Mb|
|ePub File Size:||6.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
Exemestane trade name Aromasin is a drug used to treat breast cancer. It is a member of the class of drugs known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors ERsand are called ER-positive.
[Users Choice] Anabole Steroide Das Schwarze Buch Zum Downloaden
They may also be called estrogen-responsive, hormonally-responsive, or hormone-receptor-positive. Aromatase is an anavole that synthesizes estrogen.
Aromatase inhibitors block the synthesis of estrogen. This lowers the estrogen level, and slows the growth of cancers. Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy.
Exemestane anqbole also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
The drug is contraindicated in premenopausal women, which of course includes pregnant and lactating women. Nausea and fatigue are mainly observed in patients with advanced breast cancer. Exemestane has androgenic properties similarly to formestane and can produce androgenic side effects such as acne and weight gainalthough these are generally associated with supratherapeutic dosages of the drug.
No life-threatening overdosing is known in humans, but only in animal studies with to fold doses adjusted to body surface area.
Exemestane is metabolized by the liver enzyme CYP3A4. Other 3A4 inductors such as carbamazepine and St John’s Wort are expected to have similar effects. Estrogens probably reduce exemestane effectiveness: The main source of estrogen is the ovaries in premenopausal women, while in post-menopausal women most of the body’s estrogen is produced via the conversion of androgens into estrogen by the aromatase enzyme in the peripheral tissues i.
Estrogen is produced locally via the actions of the aromatase enzyme in these peripheral tissues where it acts locally. Any circulating estrogen in post-menopausal women as well as men is the result of estrogen escaping local metabolism and entering the circulatory system. Exemestane is an irreversible, steroidal aromatase inactivator of type I, structurally related to the natural substrate 4-androstenedione.
It acts as a false substrate for the aromatase enzyme, and is processed to an intermediate that binds irreversibly to the active site of the enzyme causing its inactivation, an effect also known as ” suicide inhibition. Type II aromatase inhibitors such as anastrozole and letrozoleby contrast, are not steroids and work by interfering with the aromatase’s heme.
Exemestane is quickly absorbed from the gut, but undergoes a strong first-pass effect in the liver. Highest blood plasma concentrations are reached after 1. Maximal aromatase inhibition occurs after two to three days. The liver enzyme CYP3A4 oxidizes the methylidene group in position 6, and the keto group on the five-membered ring is reduced by aldo-keto reductases to an alcohol. The terminal half-life is 24 hours. Exemestane is known chemically as 6-methylideneandrosta-1,4-diene-3,dione.
Like the aromatase inhibitors formestane and atamestaneexemestane is a steroid that is structurally similar to 4-androstenedione, the natural substrate of aromatase. It is distinguished from the natural substance only by the methylidene group in position 6 and an additional double bond in position 1.
Exemestane has been used in doping to raise luteinizing hormone LH and follicle stimulating hormone FSH levels, which in turn increases the ratio of male over female sexual hormones and so improves performance. The drug also counteracts gynecomastia as well as fat and water retention following excessive aromatase production due to testosterone doping.
Along with other aromatase inhibitors, exemestane is on the World Anti-Doping Agency ‘s list of prohibited substances. Sdhwarz phase III trial results in showed that adding everolimus to exemestane therapy against advanced breast cancer can significantly improve progression-free survival compared with exemestane shcwarz alone.
A Phase III trial was reported inconcluding that the use of exemestane in postmenopausal women at an increased risk for breast cancer reduced the incidence of invasive breast cancer. D Evidence of risk. Austria-Codex in German 62nd ed. Arzneimittelwirkungen in German 8 ed.
Der ECA Stack mit Ephedrin
Medizinische Chemie in German. Retrieved on 12 December American Society of Clinical Oncology. Retrieved June 6, Alfatradiol Certain androgenic-anabolic steroids e. Benzestrol Bifluranol Chlorotrianisene Dienestrol Dienestrol diacetate Diethylstilbestrol stilbestrol Diethylstilbestrol diacetate Diethylstilbestrol dilaurate Diethylstilbestrol dipalmitate stilpalmitate Diethylstilbestrol dipropionate Diethylstilbestrol disulfate Diethylstilbestrol monobenzyl ether Dimestrol diethylstilbestrol dimethyl ether Fosfestrol diethylstilbestrol diphosphate Mestilbol diethylstilbestrol monomethyl ether Doisynoestrol fenocycline Hexestrol Hexestrol diacetate Hexestrol dicaprylate Hexestrol diphosphate Hexestrol dipropionate Methallenestril Methestrol dipropionate promethestrol dipropionate Paroxypropione Quadrosilan Zeranol.
Anastrozole Exemestane Fadrozole Formestane Letrozole.
Catherine Gilbert wants to Agent Orange Victims Should Be Listed on the Memorial wall · Causes
Mixed mechanism of action: L -arginineL -lysineL -ornithine Osteocalcin Testosterone. Steroid hormone metabolism modulators.
Liver CYP3A4aldo-keto reductase.